Advanced BioMedical Technologies, Inc.
ABMT
$0.0004
$0.000133.33%
OTC PK
| 07/31/2021 | 04/30/2021 | 01/31/2021 | 10/31/2020 | 07/31/2020 | |
|---|---|---|---|---|---|
| Revenue | 50.41% | 53.61% | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 50.41% | 53.61% | -- | -- | -- |
| Cost of Revenue | -32.13% | -28.82% | -- | -- | -- |
| Gross Profit | 159.37% | 160.19% | -- | -- | -- |
| SG&A Expenses | 51.74% | 46.02% | -- | -- | -- |
| Depreciation & Amortization | -0.80% | 38.28% | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -6.40% | -6.76% | -- | -- | -- |
| Operating Income | 14.76% | 15.37% | -- | -- | -- |
| Income Before Tax | -3.68% | -3.47% | -- | -- | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.68% | -3.47% | -- | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.68% | -3.47% | -- | -- | -- |
| EBIT | 14.76% | 15.37% | -- | -- | -- |
| EBITDA | 14.71% | 15.08% | -- | -- | -- |
| EPS Basic | -2.88% | -1.89% | -- | -- | -- |
| Normalized Basic EPS | -3.08% | -1.52% | -- | -- | -- |
| EPS Diluted | -57.35% | -54.29% | -- | -- | -- |
| Normalized Diluted EPS | -3.08% | -1.52% | -- | -- | -- |
| Average Basic Shares Outstanding | 0.44% | 0.48% | -- | -- | -- |
| Average Diluted Shares Outstanding | 0.50% | 0.62% | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |